Guardant Health (GH) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -29.4 | -0.58 | -0.43 | -10.9 | -35.6 | -32.5 | ||
| Changes by years, y/y, % | -43% | -98% | -27% | +2 447% | +227% | -7.2% | |||
Guardant Health. EV/EBITDA
Guardant Health. EV/EBITDA, changes, %
Guardant Health (GH) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -15.9 | -19.4 | -24.1 | -36.5 | -32.6 | -32.5 | |
| Changes by years, y/y, % | +2 914% | +2 726% | +256% | +233% | +105% | |||
| Changes by quarters, q/q, % | +45% | +23% | +24% | +51% | -11% | |||